Concord Biotech

Quarterly
Consolidated
ParticularsJun '25Sep '25Dec '25Mar '26Jun '26
Revenue217.67260.41287.75341.43270.32
Expenses160.43177.02197.61227.17193.25
EBITDA75.08101.84108.96133.8895.20
Operating Profit58.7985.7486.24114.1678.38
Profit Before Tax58.7385.6886.15114.0878.35
Net Profit44.0663.0663.6488.4757.70
Financial Ratios
Operating Profit Margin37.54%42.15%37.79%41.00%37.47%
Net Profit Margin21.60%25.73%24.08%27.23%22.73%
Earning Per Share (Diluted)4.216.036.088.465.52
Dividends Per Share0.000.000.000.000.00